• Department of Cardiovascular Surgery, Xinqiao Hospital, the Third Military Medical University, Chongqing 400037 , P. R. China.;
Export PDF Favorites Scan Get Citation

Erythropoietin (EPO) is known as a classical hematopoietic growth factor, which has been used to treat anemia caused by different reasons. In recent years, EPO's non-hematopoietic biological effects have gradually become a focus. Among these effects, EPO's tissue protection is most attractive and EPO has been proved to protect many different tissues and organs. Myocardial protection has always been the important and key topic in the field of cardiovascular diseases. Reports about EPO's myocardial protective effects have been published in the recent two years, which direct the research about myocardial protection with new ideas. In this article, the discoveries and unsolved problems associated with EPO's myocardial protection were reviewed.

Citation: QIN Chuan,XIAO Yingbin.. Advances in Erythropoietin's Myocardial Protective Effects. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2006, 13(2): 113-116. doi: Copy

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved